Hovering consistently higherI became a shareholder of DBG earlier this year when it was trading in the $0.08- $0.09 range. For it to consistently hover where it has been in the $0.2X range for so long without fresh assay results, is not something I can complain about. Based on the new developments brewing versus what pushed the share price higher in the past, as well as factoring in the share structure of DBG, there will be a substantial increase in the share price between now and Feb. Pinpointing when exactly within that time frame is anyone's guess.